174 related articles for article (PubMed ID: 38778087)
1. Drug screening on digital microfluidics for cancer precision medicine.
Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
[TBL] [Abstract][Full Text] [Related]
2. Drug screening of cancer cell lines and human primary tumors using droplet microfluidics.
Wong AH; Li H; Jia Y; Mak PI; Martins RPDS; Liu Y; Vong CM; Wong HC; Wong PK; Wang H; Sun H; Deng CX
Sci Rep; 2017 Aug; 7(1):9109. PubMed ID: 28831060
[TBL] [Abstract][Full Text] [Related]
3. Digital Microfluidics with an On-Chip Drug Dispenser for Single or Combinational Drug Screening.
Li C; Zhai J; Jia Y
Methods Mol Biol; 2023; 2679():25-39. PubMed ID: 37300607
[TBL] [Abstract][Full Text] [Related]
4. Three-gradient constructions in a flow-rate insensitive microfluidic system for drug screening towards personalized treatment.
Shen S; Zhang X; Zhang F; Wang D; Long D; Niu Y
Talanta; 2020 Feb; 208():120477. PubMed ID: 31816765
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic co-culture system for cancer migratory analysis and anti-metastatic drugs screening.
Mi S; Du Z; Xu Y; Wu Z; Qian X; Zhang M; Sun W
Sci Rep; 2016 Oct; 6():35544. PubMed ID: 27762336
[TBL] [Abstract][Full Text] [Related]
6. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
7. Development of a Microfluidic Array to Study Drug Response in Breast Cancer.
Virumbrales-Muñoz M; Livingston MK; Farooqui M; Skala MC; Beebe DJ; Ayuso JM
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801265
[TBL] [Abstract][Full Text] [Related]
8. High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications.
Mencattini A; De Ninno A; Mancini J; Businaro L; Martinelli E; Schiavoni G; Mattei F
Methods Enzymol; 2020; 632():479-502. PubMed ID: 32000911
[TBL] [Abstract][Full Text] [Related]
9. A microfluidics platform for combinatorial drug screening on cancer biopsies.
Eduati F; Utharala R; Madhavan D; Neumann UP; Longerich T; Cramer T; Saez-Rodriguez J; Merten CA
Nat Commun; 2018 Jun; 9(1):2434. PubMed ID: 29934552
[TBL] [Abstract][Full Text] [Related]
10. The prospects of tumor chemosensitivity testing at the single-cell level.
Yang C; Yang C; Yarden Y; To KKW; Fu L
Drug Resist Updat; 2021 Jan; 54():100741. PubMed ID: 33387814
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Screening of Anti-cancer Drugs Using a Microfluidic Spheroid Culture Device with a Concentration Gradient Generator.
Lee Y; Chen Z; Lim W; Cho H; Park S
Curr Protoc; 2022 Sep; 2(9):e529. PubMed ID: 36066205
[TBL] [Abstract][Full Text] [Related]
12. Cancer drug screening with an on-chip multi-drug dispenser in digital microfluidics.
Zhai J; Li C; Li H; Yi S; Yang N; Miao K; Deng C; Jia Y; Mak PI; Martins RP
Lab Chip; 2021 Dec; 21(24):4749-4759. PubMed ID: 34761772
[TBL] [Abstract][Full Text] [Related]
13. THz Spectroscopy for a Rapid and Label-Free Cell Viability Assay in a Microfluidic Chip Based on an Optical Clearing Agent.
Yang K; Yang X; Zhao X; Lamy de la Chapelle M; Fu W
Anal Chem; 2019 Jan; 91(1):785-791. PubMed ID: 30335363
[TBL] [Abstract][Full Text] [Related]
14. Application of microfluidic technology in cancer research and therapy.
Azadi S; Aboulkheyr Es H; Kulasinghe A; Bordhan P; Ebrahimi Warkiani M
Adv Clin Chem; 2020; 99():193-235. PubMed ID: 32951637
[TBL] [Abstract][Full Text] [Related]
15. Selective Targeting of Tumor Cells in a Microfluidic Tumor Model with Multiple Cell Types.
van de Crommert B; Palacio-Castañeda V; Verdurmen WPR
Methods Mol Biol; 2024; 2804():237-251. PubMed ID: 38753152
[TBL] [Abstract][Full Text] [Related]
16. Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification.
Castven D; Becker D; Czauderna C; Wilhelm D; Andersen JB; Strand S; Hartmann M; Heilmann-Heimbach S; Roth W; Hartmann N; Straub BK; Mahn FL; Franck S; Pereira S; Haupts A; Vogel A; Wörns MA; Weinmann A; Heinrich S; Lang H; Thorgeirsson SS; Galle PR; Marquardt JU
Int J Cancer; 2019 Jun; 144(11):2782-2794. PubMed ID: 30485423
[TBL] [Abstract][Full Text] [Related]
17. Drug effects analysis on cells using a high throughput microfluidic chip.
Gong Z; Zhao H; Zhang T; Nie F; Pathak P; Cui K; Wang Z; Wong S; Que L
Biomed Microdevices; 2011 Feb; 13(1):215-9. PubMed ID: 20978852
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Static Molecular Gradients in a High-Throughput Drug Screening Microfluidic Assay.
Szafran RG; Wiatrak B
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770793
[TBL] [Abstract][Full Text] [Related]
19. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.
Xing F; Liu YC; Huang S; Lyu X; Su SM; Chan UI; Wu PC; Yan Y; Ai N; Li J; Zhao M; Rajendran BK; Liu J; Shao F; Sun H; Choi TK; Zhu W; Luo G; Liu S; Xu L; Chan KL; Zhao Q; Miao K; Luo KQ; Ge W; Xu X; Wang G; Liu TM; Deng CX
Theranostics; 2021; 11(19):9415-9430. PubMed ID: 34646378
[TBL] [Abstract][Full Text] [Related]
20. Personalized
Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
